Literature DB >> 27816801

Medical cannabis and mental health: A guided systematic review.

Zach Walsh1, Raul Gonzalez2, Kim Crosby3, Michelle S Thiessen3, Chris Carroll3, Marcel O Bonn-Miller4.   

Abstract

This review considers the potential influences of the use of cannabis for therapeutic purposes (CTP) on areas of interest to mental health professionals, with foci on adult psychopathology and assessment. We identified 31 articles relating to the use of CTP and mental health, and 29 review articles on cannabis use and mental health that did not focus on use for therapeutic purposes. Results reflect the prominence of mental health conditions among the reasons for CTP use, and the relative dearth of high-quality evidence related to CTP in this context, thereby highlighting the need for further research into the harms and benefits of medical cannabis relative to other therapeutic options. Preliminary evidence suggests that CTP may have potential for the treatment of PTSD, and as a substitute for problematic use of other substances. Extrapolation from reviews of non-therapeutic cannabis use suggests that the use of CTP may be problematic among individuals with psychotic disorders. The clinical implications of CTP use among individuals with mood disorders are unclear. With regard to assessment, evidence suggests that CTP use does not increase risk of harm to self or others. Acute cannabis intoxication and recent CTP use may result in reversible deficits with the potential to influence cognitive assessment, particularly on tests of short-term memory.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Assessment; Medical cannabis; Psychopathology; Substance use

Mesh:

Substances:

Year:  2016        PMID: 27816801     DOI: 10.1016/j.cpr.2016.10.002

Source DB:  PubMed          Journal:  Clin Psychol Rev        ISSN: 0272-7358


  52 in total

1.  Cannabinoid modulation of corticolimbic activation to threat in trauma-exposed adults: a preliminary study.

Authors:  Christine A Rabinak; Ashley Blanchette; Nicole L Zabik; Craig Peters; Hilary A Marusak; Allesandra Iadipaolo; Farrah Elrahal
Journal:  Psychopharmacology (Berl)       Date:  2020-03-11       Impact factor: 4.530

2.  Characteristics of Canadians likely to try or increase cannabis use following legalization for nonmedical purposes: a cross-sectional study.

Authors:  Harman S Sandhu; Laura N Anderson; Jason W Busse
Journal:  CMAJ Open       Date:  2019-06-14

3.  Pharmacists should counsel users of medical cannabis, but should they be dispensing it?

Authors:  Paul Grootendorst; Rajivi Ranjithan
Journal:  Can Pharm J (Ott)       Date:  2018-12-12

Review 4.  Cannabis regulatory science: risk-benefit considerations for mental disorders.

Authors:  Jacob T Borodovsky; Alan J Budney
Journal:  Int Rev Psychiatry       Date:  2018-05-29

5.  Cannabis and Cannabinoids in Mood and Anxiety Disorders: Impact on Illness Onset and Course, and Assessment of Therapeutic Potential.

Authors:  Sabrina L Botsford; Sharon Yang; Tony P George
Journal:  Am J Addict       Date:  2019-10-02

6.  Cannabis industry and medical cannabis clinics need regulation.

Authors:  Meldon Kahan; Anita Srivastava; Sarah Clarke
Journal:  Can Fam Physician       Date:  2019-12       Impact factor: 3.275

7. 

Authors:  Meldon Kahan; Anita Srivastava; Sarah Clarke
Journal:  Can Fam Physician       Date:  2019-12       Impact factor: 3.275

Review 8.  Changing landscape of cannabis: novel products, formulations, and methods of administration.

Authors:  Tory R Spindle; Marcel O Bonn-Miller; Ryan Vandrey
Journal:  Curr Opin Psychol       Date:  2019-04-09

9.  State medical marijuana laws, cannabis use and cannabis use disorder among adults with elevated psychological distress.

Authors:  Ryan K McBain; Eunice C Wong; Joshua Breslau; Amy L Shearer; Matthew S Cefalu; Elizabeth Roth; M Audrey Burnam; Rebecca L Collins
Journal:  Drug Alcohol Depend       Date:  2020-07-24       Impact factor: 4.492

Review 10.  Affect and cannabis use in daily life: a review and recommendations for future research.

Authors:  Andrea M Wycoff; Jane Metrik; Timothy J Trull
Journal:  Drug Alcohol Depend       Date:  2018-08-15       Impact factor: 4.492

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.